AD

Zydus Lifesciences receives USFDA approval for Cyanocobalamin Injection

Logo Business Standard
Business Standard
By Capital Market

Zydus Lifesciences has received final approval from the USFDA to market Cyanocobalamin Injection in the strengths of 1,000 mcg/mL,10,000 mcg/10 mL (1,000 mcg/mL), and 30,000 mcg/30 mL (1,000 mcg/mL) Multiple-Dose Vials. (US RLD: Cyanocobalamin).

AD
AD

Cyanocobalamin injection is used to treat and prevent lack of vitamin B12 that may be caused due to pernicious anemia (lack of a natural substance needed to absorb vitamin B12 from the intestine), certain diseases, infections or medications decrease the amount of vitamin B12 absorbed from food.

The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat.

The group now has 331 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.

Powered by Capital Market - Live News

Continue read on business-standard.com

AD
Logo Business Standard
Zydus Lifesciences (formerly known as Cadila Healthcare) has received Prior Approval Supplement (PAS) approval from the USFDA to market Mycophenolate Mofetil...

Logo Business Standard
Zydus Lifesciences (formerly known as Cadila Healthcare) received Prior Approval Supplement (PAS) approval from the USFDA to market Mycophenolate Mofetil for...

Logo Business Standard
Zydus Lifesciences rose 1.45% to Rs 368.35 after the company announced that it will be manufacturing and supplying Sagent's Caffeine Citrate Oral Solution in...

Logo Business Standard
Used in treatment of breathing problem in premature infants Zydus Lifesciences announced that it will be manufacturing and supplying Sagent's Caffeine...

Logo Business Standard
Used in treatment of seizures Indoco Remedies announced that the United States Food & Drug Administration (USFDA) has approved the ANDA Lacosamide...

Logo Benzinga
Selenious Acid, in this new concentration and vial size has been specifically designed for pediatric and neonatal patients weighing less than 7 kg MELVILLE,...

Logo Business Standard
Lupin today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application...

Logo Business Standard
Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug...

Logo Nasdaq
(RTTNews) - Teva Pharmaceuticals has initiated a recall of lot 31329657B of IDArubicin Hydrochloride Injection USP 5 mg/5 mL vial in the United States due to...

Logo Indiatimes
Pharma major Dr Reddy's Laboratories Ltd on Tuesday said it has launched its generic Methylprednisolone Sodium Succinate for injection, indicated for various...

Logo Business Standard
Alembic Pharmaceuticals today announced that its wholly owned subsidiary, Aleor Dermaceuticals (Aleor) has received final approval from the US Food &...

Logo Business Standard
SMS Lifesciences on Friday announced that its manufacturing facility located at Sangareddy district in Telangana completed USFDA without any observations....

Logo Business Standard
Zydus Lifesciences’ (formerly known as Cadila Healthcare) three-dose Covid vaccine — ZyCoV-D — has received the subject expert committee (SEC) approval for a...

Logo Business Standard
Alembic Pharmaceuticals advanced 3.97% to Rs 755.35 after the company announced the receipt of final approval from the US Food & Drug Administration...

Logo Business Standard
SMS Lifesciences jumped 15.2% to Rs 909.85 after the drug maker announced that its manufacturing facility located at Sangareddy district in Telangana...

Logo Business Standard
Gufic Biosciences soared 10.65% to Rs 274.25 on securing permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation...

Logo Business Standard
Homegrown pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic version of Desvenlafaxine...

Logo Indiatimes
NEW DELHI: SMS Lifesciences skyrocketed 18.9 per cent in early trade Monday after the United States Food and Drug Administration (USFDA) completed an...

Logo Benzinga
Dr. Reddy's Laboratories Ltd. ((BSE: 500124,DRREDDYRDYDRREDDY along with its subsidiaries together referred to as Dr. Reddy's)) today announced the launch of...

Logo Benzinga
CABENUVA offers virologically suppressed adolescents 12 years of age or older living with HIV-1 an injectable treatment option with as few as six dosing days...